Discover 1,123 paid clinical trials in Alabama. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Alabama provides a diverse range of research opportunities for healthy volunteers and individuals with specific health conditions. Leading research centers in Birmingham, Montgomery, and Mobile are seeking participants, offering access to innovative treatments and cutting-edge medical care.
Filter
1
Filter results
Results: 1,123
A Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
for
Ovarian Cancer
Location: Boston MA, Worcester MA, New York NY, Hackensack NJ,
Sponsor: Incyte Corporation
Sex: Female
Age: 18 - 70+
Code: NCT07023627
Phase 2, Recruiting
A Study of mRNA-2808 in Participants With Relapsed or Refractory Multiple Myeloma
for
Relapsed or Refractory Multiple Myeloma
Location: Boston MA, New York NY, Philadelphia PA, Charlotte NC,
Sponsor: ModernaTX, Inc.
Sex: All
Age: 18+
Code: NCT07116616
Phase 1, Phase 2, Recruiting
Evaluating BL-M14D1 in Subjects With Locally Advanced or Metastatic Small Cell Lung Cancer and Neuroendocrine Tumors
for
Small Cell Lung Cancer Metastatic or Locally Advanced,
Location: New Haven CT, New York NY, Hackensack NJ,
Sponsor: SystImmune Inc.
Sex: All
Age: 18+
Code: NCT07080242
Phase 1, Recruiting
A Study Comparing Higher Dose Chemotherapy Over a Shorter Amount of Time to Lower Dose Chemotherapy Plus Maintenance Over a Longer Amount of Time in Patients With Newly Diagnosed Intermediate-Risk Rhabdomyosarcoma (IR RMS)
Location: St. John's, Halifax, Bangor ME, Scarborough ME,
Sponsor: Children's Oncology Group
Sex: All
Age: 1 - 30
Code: NCT03126916
Phase 3, Recruiting
Pilot of Reconnecting to Internal Sensations and Experiences in Undergraduates
for
Suicidal Ideation, Eating Disorder Symptom
Location: Auburn AL
Sponsor: Auburn University
Sex: All
Age: 18 - 65
Code: NCT05285111
Recruiting
TLN-372 in Advanced KRAS Mutant Solid Tumors
for
KRAS Mutant Solid Tumors
Location: Boston MA, New York NY, Toronto, Grand Rapids MI,
Sponsor: Treeline Biosciences, Inc.
Sex: All
Age: 18+
Code: NCT07204340
Phase 1, Recruiting
Yogic Breathing Exercise and Meditation for People With Spinal Cord Disorders
for
Spinal Cord Disorders
Location: Birmingham AL
Sponsor: University of Alabama at Birmingham
Sex: All
Age: 18 - 70+
Code: NCT07655531
Recruiting
Improving Needs Among Older Adults
for
Critical Illness, Palliative Care, Older Adults,
Location: New York NY, Durham NC, Charleston SC, Birmingham AL
Sponsor: Duke University
Sex: All
Age: 18+
Code: NCT06588556
Recruiting
A Study of Surovatamig (AZD0486) Plus Rituximab in Previously Untreated Follicular Lymphoma Patients
for
Untreated Follicular Lymphoma
Location: Halifax, New Haven CT, Quebec, Chicoutimi, New York NY,
Sponsor: AstraZeneca
Sex: All
Age: 18 - 70+
Code: NCT06549595
Phase 3, Recruiting
A Study to Determine the Recommended Dose and Schedule, and Evaluate the Safety and Preliminary Efficacy of Mezigdomide in Combination With Elranatamab in Participants With Relapsed and/or Refractory Multiple Myeloma
for
Multiple Myeloma
Location: Halifax, New Haven CT, Hackensack NJ, Toronto,
Sponsor: Celgene
Sex: All
Age: 18+
Code: NCT06988488
Phase 1, Phase 2, Recruiting
Trial of 2 Step ATG for Acute GVHD Prevention Post Myeloablative Allogeneic Stem Cell Transplant
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
for
Metastatic Castration Sensitive Prostate Cancer (mCSPC),
Location: Commack NY, Seaford NY, Uniondale NY, Lake Success NY,
Sponsor: Pfizer
Sex: Male
Age: 18+
Code: NCT07028853
Phase 3, Recruiting
Selumetinib for the Prevention of Plexiform Neurofibroma Growth in NF Type 1
for
Neurofibromatosis 1, Plexiform Neurofibroma
Location: Boston MA, Philadelphia PA, Baltimore MD,
Sponsor: University of Alabama at Birmingham
Sex: All
Age: 1 - 8
Code: NCT06188741
Phase 2, Recruiting
Phase 3 Study of LUM-201 in Children With Growth Hormone Deficiency
for
Growth Hormone Deficiency (GHD)
Location: Staten Island NY, Washington D.C. DC,
Sponsor: Lumos Pharma
Sex: All
Age: 3 - 11
Code: NCT06948214
Phase 3, Recruiting
Continued Pressure for Alveolar Protection (CPAP Trial)
for
Bronchopulmonary Dysplasia (BPD)
Location: Philadelphia PA, Durham NC, Cleveland OH, Atlanta GA,
Sponsor: NICHD Neonatal Research Network
Sex: All
Age: 0
Code: NCT07417111
Recruiting
Metastatic Ewing's Trial Testing Schedule Enhancement to Improve Outcomes
for
Metastatic Ewing Sarcoma
Location: The Bronx NY, Durham NC, Miami FL, Buffalo NY,
Sponsor: H. Lee Moffitt Cancer Center and Research Institute